Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Express Scripts
Baxter
Mallinckrodt

Last Updated: November 27, 2022

Alprostadil - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for alprostadil
US Patents:0
Tradenames:6
Applicants:5
NDAs:8
Drug Master File Entries: 7
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 98
Clinical Trials: 38
Patent Applications: 7,825
What excipients (inactive ingredients) are in alprostadil?alprostadil excipients list
DailyMed Link:alprostadil at DailyMed
Recent Clinical Trials for alprostadil

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kafrelsheikh UniversityN/A
First Hospital of Jilin UniversityPhase 4
The First Hospital of Jilin UniversityPhase 4

See all alprostadil clinical trials

Medical Subject Heading (MeSH) Categories for alprostadil

US Patents and Regulatory Information for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020379-002 Jul 6, 1995 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020379-004 May 19, 1997 AP RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-006 Jul 30, 1998 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-007 Jul 30, 1998 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 AP RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-001 Oct 31, 1997 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020755-003 Oct 1, 1997 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 See Plans and Pricing See Plans and Pricing
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 See Plans and Pricing See Plans and Pricing
Pfizer CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 See Plans and Pricing See Plans and Pricing
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-003 Nov 19, 1996 See Plans and Pricing See Plans and Pricing
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-002 Nov 19, 1996 See Plans and Pricing See Plans and Pricing
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-004 Nov 19, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Johnson and Johnson
Moodys
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.